Contrast-enhanced endoscopic ultrasonography in digestive diseases

Journal of Gastroenterology

Volumn 47, Issue 10, 2012, Pages 1063-1072

  Hirooka, Yoshiki ^a   Itoh, Akihiro ^b   Kawashima, Hiroki ^b   Ohno, Eizaburo ^a   Itoh, Yuya ^b   Nakamura, Yosuke ^a   Hiramatsu, Takeshi ^b   Sugimoto, Hiroyuki ^b   Sumi, Hajime ^b   Hayashi, Daijiro ^b   Ohmiya, Naoki ^b   Miyahara, Ryoji ^b   Nakamura, Masanao ^b   Funasaka, Kohei ^a   Ishigami, Masatoshi ^b   Katano, Yoshiaki ^b   Goto, Hidemi ^a,b  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biliary diseases; Contrast agents; Contrast enhanced EUS (CE EUS); Gastrointestinal tract; Pancreatic diseases; Time intensity curve

Indexed keywords

CONTRAST MEDIUM; PERFLUBUTANE; SHU 508;

ANGIOGRAPHY; BILIARY TRACT DISEASE; COLOR DOPPLER BASED CONTRAST ENHANCED ENDOSCOPIC ULTRASONOGRAPHY; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCED ENDOSCOPIC ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM DISEASE; DIGITAL IMAGING; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC ULTRASONOGRAPHIC ANGIOGRAPHY; ESOPHAGUS CANCER; GALLBLADDER DISEASE; HARMONIC IMAGING; HARMONIC IMAGING CONTRAST ENHANCED ENDOSCOPIC ULTRASONOGRAPHY; HEMODYNAMICS; HUMAN; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH TUMOR; SUBMUCOSAL STOMACH TUMOR; THREE DIMENSIONAL IMAGING; UPPER GASTROINTESTINAL TRACT;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM DISEASES; ENDOSONOGRAPHY; HUMANS; ULTRASONOGRAPHY, DOPPLER;

EID: 84867987774     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0662-4     Document Type: Review

References (54)

1. 2 microbubbles. Radiology. 1986;161(3):701-5.
2. Hirooka Y, Naitoh Y, Goto H, Ito A, Taki T, Hayakawa T. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc. 1997;46(2):166-9.
3. Kato T, Tsukamoto Y, Naitoh Y, Hirooka Y, Furukawa T, Hayakawa T. Ultrasonographic and endoscopic ultrasonographic angiography in pancreatic mass lesions. Acta Radiol. 1995;36(4):381-7.
4. Kuroiwa M, Tsukamoto Y, Naitoh Y, Hirooka Y, Furukawa T, Katou T. New technique using intraductal ultrasonography for the diagnosis of bile duct cancer. J Ultrasound Med. 1994;13(3):189-95.
5. Reddy NK, Ioncica AM, Saftoiu A, Vilmann P, Bhutani MS. Contrast-enhanced endoscopic ultrasonography. World J Gastroenterol. 2011;17(1):42-8.
6. Bhutani MS, Hoffman BJ, van Velse A, Hawes RH. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist). Endoscopy. 1997;29(7):635-9.
7. Hirooka Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y, et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol. 1998;93(4):632-5.
8. Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S, Watanabe Y, et al. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc. 1998;48(4):406-10.
9. Nomura N, Goto H, Niwa Y, Arisawa T, Hirooka Y, Hayakawa T. Usefulness of contrast-enhanced EUS in the diagnosis of upper GI tract diseases. Gastrointest Endosc. 1999;50(4):555-60.
10. Sakamoto H, Kitano M, Matsui S, Kamata K, Komaki T, Imai H, et al. Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc. 2011;73(2):227-37.
11. Niwa K, Hirooka Y, Itoh A, Hashimoto S, Hirai T, Takeda K, et al. Preclinical study of endoscopic ultrasonography with electronic radial scanning echoendoscope. J Gastroenterol Hepatol. 2003;18(7):828-35.
12. Niwa K, Hirooka Y, Niwa Y, Itoh A, Ohmiya N, Hashimoto S, et al. Comparison of image quality between electronic and mechanical radial scanning echoendoscopes in pancreatic diseases. J Gastroenterol Hepatol. 2004;19(4):454-9.
13. Ishikawa H, Hirooka Y, Itoh A, Hashimoto S, Okada N, Itoh T, et al. A comparison of image quality between tissue harmonic imaging and fundamental imaging with an electronic radial scanning echoendoscope in the diagnosis of pancreatic diseases. Gastrointest Endosc. 2003;57(7):931-6.
14. Becker D, Strobel D, Bernatik T, Hahn EG. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc. 2001;53(7):784-9.
15. Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol. 2006;12(2):246-50.
16. Kanamori A, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol. 2006;101(1):45-51.
17. Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol. 2008;6(5):590-7.
18. Hocke M, Menges M, Topalidis T, Dietrich CF, Stallmach A. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol. 2008;134(4):473-80.
19. Hocke M, Schmidt C, Zimmer B, Topalidis T, Dietrich CF, Stallmach A. Contrast enhanced endosonography for improving differential diagnosis between chronic pancreatitis and pancreatic cancer. Dtsch Med Wochenschr. 2008;133(38):1888-92.
20. Hirooka Y, Itoh A, Kawashima H, Ohno E, Ishikawa T, Matsubara H, et al. Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography. Clin Gastroenterol Hepatol. 2009;7:S63-7.
21. Ohno E, Hirooka Y, Itoh A, Ishigami M, Katano Y, Ohmiya N, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249(4):628-34.
22. Saftoiu A, Vilmann P. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound. 2009;37(1):1-17.
23. Giovannini M. The place of endoscopic ultrasound in bilio-pancreatic pathology. Gastroenterol Clin Biol. 2010;34(8-9):436-45.
24. Ishikawa T, Itoh A, Kawashima H, Ohno E, Matsubara H, Itoh Y, et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc. 2010;71(6):951-9.
25. Saftoiu A, Iordache SA, Gheonea DI, Popescu C, Malos A, Gorunescu F, et al. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc. 2010;72(4):739-47.
26. Hirooka Y, Itoh A, Kawashima H, Ohno E, Ishikawa T, Itoh Y, et al. Clinical oncology for pancreatic and biliary cancers: advances and current limitations. World J Clin Oncol. 2011;2(5):217-24.
27. Hocke M, Ignee A, Dietrich CF. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Endoscopy. 2011;43(2):163-5.
28. Kitano M, Kudo M, Sakamoto H, Komaki T. Endoscopic ultrasonography and contrast-enhanced endoscopic ultrasonography. Pancreatology. 2011;11(Suppl 2):28-33.
29. Ohno E, Itoh A, Kawashima H, Ishikawa T, Matsubara H, Itoh Y, et al. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Pancreas. 2012;41(6):855-62.
30. Sakamoto H, Kitano M, Suetomi Y, Maekawa K, Takeyama Y, Kudo M. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol. 2008;34(4):525-32.
31. Dietrich CF, Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol. 2005;43(11):1219-23.
32. Kitano M, Sakamoto H, Matsui U, Ito Y, Maekawa K, von Schrenck T, et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc. 2008;67(1):141-50.
33. Imazu H, Uchiyama Y, Matsunaga K, Ikeda K, Kakutani H, Sasaki Y, et al. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand J Gastroenterol. 2010;45(6):732-8.
34. Napoleon B, Alvarez-Sanchez MV, Gincoul R, Pujol B, Lefort C, Lepilliez V, et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy. 2010;42(7):564-70.
35. Sakamoto H, Kitano M, Kamata K, El-Masry M, Kudo M. Diagnosis of pancreatic tumors by endoscopic ultrasonography. World J Radiol. 2010;2(4):122-34.
36. Seicean A, Badea R, Stan-Iuga R, Gulei I, Pop T, Pascu O. The added value of real-time harmonics contrast-enhanced endoscopic ultrasonography for the characterisation of pancreatic diseases in routine practice. J Gastrointestin Liver Dis. 2010;19(1):99-104.
37. Seicean A, Badea R, Stan-Iuga R, Mocan T, Gulei I, Pascu O. Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses. Ultraschall Med. 2010;31(6):571-6.
38. Xia Y, Kitano M, Kudo M, Imai H, Kamata K, Sakamoto H, et al. Characterization of intra-abdominal lesions of undetermined origin by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc. 2010;72(3):637-42.
39. Hijioka S, Sawaki A, Mizuno N, Hara K, Mekky MA, El-Amin H, et al. Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma. J Med Ultrason. 2011;38(2):89-92.
40. Kitano M, Sakamoto H, Komaki T, Kudo M. New techniques and future perspective of EUS for the differential diagnosis of pancreatic malignancies: contrast harmonic imaging. Dig Endosc. 2011;23(Suppl 1):46-50.
41. Matsubara H, Itoh A, Kawashima H, Kasugai T, Ohno E, Ishikawa T, et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40(7):1073-9.
42. Romagnuolo J, Hoffman B, Vela S, Hawes R, Vignesh S. Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video). Gastrointest Endosc. 2011;73(1):52-63.
43. Imazu H, Kanazawa K, Mori N, Ikeda K, Kakutani H, Sumiyama K, et al. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma. Scand J Gastroenterol. 2012;47(7):853-60.
44. Kitano M, Kudo M, Yamao K, Takagi T, Sakamoto H, Komaki T, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol. 2012;107(2):303-10.
45. Kitano M, Sakamoto H, Kudo M. Endoscopic ultrasound: contrast enhancement. Gastrointest Endosc Clin N Am. 2012;22(2):349-58.
46. Giovannini M. Contrast-enhanced endoscopic ultrasound and elastosonoendoscopy. Best Pract Res Clin Gastroenterol. 2009;23(5):767-79.
47. Tanaka M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183-97.
48. Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents: basic principles. Eur J Radiol. 1998;27(Suppl 2):S157-60.
49. Saftoiu A, Gheonea DI. Tridimensional (3D) endoscopic ultrasounda pictorial review. J Gastrointestin Liver Dis. 2009;18(4):501-5.
50. Giovannini M. Contrast-enhanced and 3-dimensional endoscopic ultrasonography. Gastroenterol Clin North Am. 2010;39(4):845-58.
51. Hocke M, Dietrich CF. New technology-combined use of 3D contrast enhanced endoscopic ultrasound techniques. Ultraschall Med. 2011;32(3):317-8.
52. Hocke M, Ignee A, Dietrich CF. Three-dimensional contrast-enhanced endoscopic ultrasound for the diagnosis of autoimmune pancreatitis. Endoscopy. 2011;43:Suppl 2 UCTN:E381-2.
53. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45(2):89-95.
54. Anderson CR, Hu X, Zhang H, Tlaxca J, Decleves AE, Houghtaling R, et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol. 2011;46(4):215-24.